T-cell Lymphoma

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Do These Stocks Deserve Your Support?

Published December 4, 2008, 12:07 pm, The Motley Fool

Shareholder-friendly stocks that have been marked to underperform the market.

Discover News | Full Story


More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current ...

Published December 3, 2008, 10:25 pm, PR Newswire via Yahoo! Finance

Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH

Discover News | Full Story


Allos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008

Published December 3, 2008, 5:33 am, Centre Daily Times

Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that it will host an analyst and investor briefing in conjunction with the 50 th Annual Meeting of the American Society of Hematology (ASH) from 6:00 p.m. to 8:00 p.m. (Pacific) on Monday, December 8, 2008.

Discover News | Full Story


U.S FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Follicular Lymphoma

Published December 2, 2008, 9:13 am, Medical News Today

Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to the Company's novel antifolate, pralatrexate (PDX), for the treatment of patients with follicular lymphoma.

Discover News | Full Story


Merck working with National Comprehensive Cancer Network on research

Published December 2, 2008, 8:24 am, BizJournals

The National Comprehensive Cancer Network said Tuesday it has received a $1 million research grant from Merck & Co. Inc. to fund clinical trials of new combination treatments for cancer patients. (MRK)

Discover News | Full Story


Combination Cancer Therapy is Focus of $1M Merck Research Grant Received by NCCN

Published December 2, 2008, 6:00 am, Business Wire via Yahoo! Finance

FORT WASHINGTON, Pa.----The National Comprehensive Cancer Network recently received a $1M research grant from Merck & Co., Inc. to fund clinical trials focusing on innovative combinations of vorinostat with radiation/chemoradiation preferentially for patients with selected locally advanced non-metastatic cancers and areas of unmet medical need.

Discover News | Full Story


Allos cancer drug gets another orphan designation from FDA, protecting it from competition

Published December 1, 2008, 2:02 pm, Canadian Business

Allos Therapeutics Inc. said Monday federal regulators have granted for the second time in a week a special status to the cancer drug pralatrexate

Discover News | Full Story


Allos cancer drug candidate gets FDA orphan status

Published December 1, 2008, 1:53 pm, INO News

(AP:WESTMINSTER, Colo.) Allos Therapeutics Inc. said Monday federal regulators have granted for the second time in a week a special status to the cancer drug pralatrexate that protects it from competition if approved.

Discover News | Full Story


U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular Lymphoma

Published December 1, 2008, 1:00 pm, Business Wire via Yahoo! Finance

WESTMINSTER, Colo.----Allos Therapeutics, Inc. , a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S.

Discover News | Full Story


The symptoms of T-cell leukemia/lymphoma

Published December 1, 2008, 10:28 am, PhysOrg

Multiple lymphomatous polyposis (MLP) is an unusual form mantle cell lymphoma characterized by polyps throughout the gastrointestinal tract. Adult T-cell leukemia/lymphoma (ATLL) is a malignancy associated with retrovirus, human T-cell lymphotropic virus type 1 (HTLV-1). Although it is well-known that ATLL cells infiltrate into systemic organs including gastrointestinal (GI) tract, colonic ...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a